Navigation Links
2 Mutations Were Critical to Spread of 1918 Flu
Date:2/19/2008

The findings could aid investigation of current bird flu, experts say

TUESDAY, Feb. 19 (HealthDay News) -- New research on the spread of the 1918 influenza virus, which killed more than 50 million people worldwide, may aid research into today's potentially dangerous bird flu strain, scientists say.

MIT researchers found that the 1918 avian flu virus strain developed two mutations in a surface molecule called hemagglutinin (HA), which allowed it to bind tightly to receptors in the human upper respiratory tract. This ability to "lock in" was critical for viral transmission in humans, according to the findings, published in Feb. 18 issue of the Proceedings of the National Academy of Sciences.

"Two mutations dramatically change the HA binding affinity to receptors found in the human upper airways," said the paper's senior author Ram Sasisekharan, the Underwood Prescott Professor of Biological Engineering and Health Sciences and Technology, in a prepared statement.

Sasisekharan and colleagues previously reported in January's Nature Biotechnology that flu viruses can only bind to human respiratory cells if they match the shape of sugar (or glycan) receptors found on those cells. The receptors, known as alpha 2-6 in humans, come in two shapes -- one resembling a cone; the other an open umbrella.

In the new study, the team discovered that for avian flu viruses to transmit from birds to humans, they must gain the ability to bind tightly or with a high affinity to the umbrella-shaped receptors.

"The affinity between the influenza virus HA and the glycan receptors appears to be a critical determinant for viral transmission," Sasisekharan said.

The researchers compared the influenza virus that caused the 1918 pandemic with two similar strains (called NY18 and AV18) that differ from it by only one or two amino acids.

Using ferrets (which are susceptible to human flu strains), researchers had earlier found that the pandemic virus transmitted efficiently between ferrets, while the NY18 strain proved only slightly infectious and AV18 not at all infectious.

While slightly infectious NY18 binded to the umbrella-shaped glycan receptors, it did not do it as well as the highly infectious pandemic strain did. The non-infectious AV18 strain had no affinity for the receptors.

Another strain, TX18, proved much more infectious than NY18, and it bonded with high affinity to the umbrella-shaped receptors.

Researchers from the Centers for Disease Control and Prevention reported on the infectiousness of these strains last year, but the MIT study is the first to explain the biochemical reason causing these differences.

More information

The U.S. Centers for Disease Control and Prevention has more about influenza.



-- Kevin McKeever



SOURCE: Massachusetts Institute of Technology, news release, Feb. 18, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Gene Mutations May Cause Rare Neonatal Diabetes
2. Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene
3. BRCA Mutations Dont Raise Breast Cancer Risk Equally
4. Genetic Mutations Boost Prostate Cancer Risk
5. Scientists explore factors contributing to DNA mutations
6. Benefit of cancer prevention surgery differs between women with BRCA1 and BRCA2 mutations
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Middle School Marks Most Critical Time to Start Ongoing Conversations About Drug and Alcohol Use With Kids
9. Oncologists are critical in managing psychiatric disorders in patients with advanced cancer
10. Consumer Specialty Products Association Highly Critical of NRDC Study on Home Air Fresheners
11. Critical blood shortages eased by new technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... ... broad access to life-saving drugs and rewarding the innovators who develop those drugs often ... , That was the message from Dana Goldman, PhD, Leonard D. Schaeffer Chair and ... who served as the keynote speaker for Western University of Health Sciences’ Ray Symposium ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... Christopher Salas-Wright finds that youth violence is declining—and at noteworthy rates. Between 2002 ... proportion of young people involved in violence in the United States. The study, ...
(Date:4/21/2017)... ... April 21, 2017 , ... Evoke Therapy Programs , ... kicked off its 4th annual Forum for Innovative Treatment Solutions (FITS), which runs ... Therapy for Mental Health and Addiction.” , FITS’ 2017 keynote presenters will ...
(Date:4/21/2017)... ... April 21, 2017 , ... Young Asset Protection, ... to communities throughout the greater Pittsburgh metropolitan region, is joining forces with the ... bicycles for differently-abled children. , Variety the Children’s Charity is a national organization ...
(Date:4/21/2017)... ... April 21, 2017 , ... The adage “Show, don’t tell” applies ... project in the company’s esteemed VISION House demonstration project series. Manifesting the concept of ... of resources they need to live affordably and abundantly without unduly taxing the resources ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017   ZappRx, Inc ., a digital ... prescribing process, today announced it closed $25 million in Series ... capital firm based in Seattle that ... Partners . The Series B round included participation from ... 2014, and GV (formerly Google Ventures). As part ...
(Date:4/20/2017)... April 20, 2017 Research and Markets ... Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key ... to their offering. ... global pharmacogenomics market was valued at US$ 7,167.6 Mn in ... 2024, expanding at a CAGR of 5.6% from 2016 to ...
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
Breaking Medicine Technology: